Brief: Armata Pharmaceuticals Announces Second Quarter 2020 Results And Provides General Corporate Update
13/08/2020 21:17
Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2020
RESULTS AND
PROVIDES GENERAL CORPORATE UPDATE
* ARMATA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.26
Source text for Eikon: ID:nPn7Z9X9Ya
Further company coverage: ARMP.A
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles